Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Jones

Showing results (221-230 of 250) with videos related to

Pageof 25
Sort By:
Hepatology (Baltimore, Md.)|January 1, 1994
Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathyA S Basile, P M Harrison, R D Hughes, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Gastroenterology|May 1, 1983
Increased blood-brain transfer in a rabbit model of acute liver failureM E Horowitz, D F Schafer, P Molnar, et al.
Biochemical and Molecular Medicine|June 1, 1996
Concurrent hormone resistance (pseudohypoparathyroidism type Ia) and hormone independence (testotoxicosis) caused by a unique mutation in the G alpha s geneJ M Nakamoto, D Zimmerman, E A Jones, et al.
European Journal of Gastroenterology & Hepatology|April 2, 1999
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?A W van Milligen de Wit, H Kuiper, L Camoglio, et al.
Gastrointestinal Endoscopy|November 14, 1997
Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitisA W van Milligen de Wit, E A Rauws, J van Bracht, et al.
Gastroenterology|December 1, 1985
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterificationC E Jahn, E J Schaefer, L A Taam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytesP A Scherle, E A Jones, M F Favata, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasisN V Bergasa, J M Schmitt, T L Talbot, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Pageof 25

Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Hepatology (Baltimore, Md.)|January 1, 1994
Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathyA S Basile, P M Harrison, R D Hughes, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Gastroenterology|May 1, 1983
Increased blood-brain transfer in a rabbit model of acute liver failureM E Horowitz, D F Schafer, P Molnar, et al.
Biochemical and Molecular Medicine|June 1, 1996
Concurrent hormone resistance (pseudohypoparathyroidism type Ia) and hormone independence (testotoxicosis) caused by a unique mutation in the G alpha s geneJ M Nakamoto, D Zimmerman, E A Jones, et al.
European Journal of Gastroenterology & Hepatology|April 2, 1999
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?A W van Milligen de Wit, H Kuiper, L Camoglio, et al.
Gastrointestinal Endoscopy|November 14, 1997
Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitisA W van Milligen de Wit, E A Rauws, J van Bracht, et al.
Gastroenterology|December 1, 1985
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterificationC E Jahn, E J Schaefer, L A Taam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytesP A Scherle, E A Jones, M F Favata, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasisN V Bergasa, J M Schmitt, T L Talbot, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Pageof 25